Status:
COMPLETED
Determining Drug Levels of Beta-lactam Antibiotics in Severe Burned Patients
Lead Sponsor:
University Hospital Schleswig-Holstein
Collaborating Sponsors:
Medical Clinic III
Dezernat Apotheke
Conditions:
Antibiotics
Severe Burn
Eligibility:
All Genders
18+ years
Brief Summary
At antibiotic stewardship of the University Hospital of Schleswig-Holsten it was noticed that there are much less studies measuring drug levels in severe burned patients than are required. Especially,...
Eligibility Criteria
Inclusion
- General
- Adult
- Receiving beta-lactam antibiotic Piperacillin/Tazobactam
- Antibiotic therapy of 3 or more days
- Given informed consent Group 1
- Severe Burn Group 2
- No Severe Burn
Exclusion
- Already in another Study
- No useful blood sample
Key Trial Info
Start Date :
May 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2016
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT03335137
Start Date
May 1 2014
End Date
December 31 2016
Last Update
November 7 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Schleswig-Holstein
Lübeck, Schleswig-Holstein, Germany, 23538